In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.

Abstract

UNLABELLED:

Guanylyl cyclase C (GC-C) is a transmembrane receptor expressed by human intestinal cells and primary and metastatic colorectal adenocarcinomas but not by extraintestinal tissues or tumors. The Escherichia coli heat-stable enterotoxin analog, STa (5--18), is a 14--amino acid peptide that selectively binds to the extracellular domain of GC-C with subnanomolar affinity. This study examined the utility of a radiolabeled conjugate of STa (5--18) to selectively target and image extraintestinal human colon cancer xenografts in vivo in nude mice.

METHODS:

The STa conjugate, ethoxyethyl-mercaptoacetamidoadipoylglycylglycine-STa (5--18) (NC100586), was synthesized and labeled with (99m)Tc to produce (99m)Tc-NC100586. This compound was intravenously administered to nude mice bearing human colon cancer xenografts, and specific targeting was evaluated by biodistribution and gamma camera imaging.

RESULTS:

In CD-1 nude mice, biodistribution and scintigraphic imaging analyses showed selective uptake of (99m)Tc-NC100586 into human colon cancer xenografts that express GC-C but not into normal tissues that do not express GC-C. Similarly, (99m)Tc-NC100586 injected intravenously into CD-1 nude mice with human colon cancer hepatic metastases selectively accumulated in those metastases, and about 5-mm foci of tumor cells were visualized after ex vivo imaging of excised livers. Accumulation of (99m)Tc-NC100586 in human colon cancer xenografts reflected binding to GC-C because (99m)Tc-NC100588, an inactive analog that does not bind to GC-C, did not selectively accumulate in cancer xenografts compared with normal tissues. Also, coadministration of excess unlabeled STa (5--18) prevented accumulation of (99m)Tc-NC100586 in human colon cancer xenografts. Furthermore, (99m)Tc-NC100586 did not selectively accumulate in Lewis lung tumor xenografts, which do not express GC-C.

CONCLUSION:

This study showed that intravenously administered STa (5--18) selectively recognizes and binds to GC-C expressed by human colon cancer cells in vivo. Also shown was the ability to exploit this selective interaction to target imaging agents to extraintestinal human colon tumors in nude mice. These results suggest the utility of STa and GC-C for the development of novel targeted imaging and therapeutic agents with high specificity for metastatic colorectal tumors in humans.

• Authors: Henry R Wolfe, Marivi Mendizabal, Elinor Lleong, Alan Cuthbertson, Vinay Desai, Shirley Pullan, Dennis K Fujii, Matthew Morrison, Richard Pither, Scott A Waldman
• Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 43 Issue 3 Pg. 392-9 (Mar 2002) ISSN: 0161-5505 [Print] United States
• PMID: 11884500 (Publication Type: Journal Article)

Chemical References

• Enterotoxins
• Organotechnetium Compounds
• Radiopharmaceuticals
• Receptors, Peptide
• technetium ethoxyethyl-mercaptoacetamidoadipoylglycylglycine-STa(5-18)
• Guanylate Cyclase
• Receptors, Enterotoxin
• Receptors, Guanylate Cyclase-Coupled

Topics

• Animals
• Colonic Neoplasms (diagnostic imaging, metabolism, pathology)
• Enterotoxins (pharmacokinetics)
• Guanylate Cyclase (metabolism)
• Humans
• Liver Neoplasms (diagnostic imaging, secondary)
• Mice
• Mice, Nude
• Neoplasm Transplantation
• Organotechnetium Compounds (pharmacokinetics)
• Radionuclide Imaging
• Radiopharmaceuticals (pharmacokinetics)
• Receptors, Enterotoxin
• Receptors, Guanylate Cyclase-Coupled
• Receptors, Peptide (metabolism)
• Tissue Distribution